New hope for moms: depression treatment opens to more women
NCT ID NCT03924492
Summary
This program provides access to ZULRESSO (brexanolone) injection for women with postpartum depression before it's widely available. Eligible adult women with postpartum depression can receive this treatment through their healthcare provider. The program requires careful medical supervision during the infusion period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.